Investigational Drug Details
| Drug ID: | D493 |
| Drug Name: | MET642 |
| Synonyms: | -- |
| Type: | Chemical drug |
| DrugBank ID: | -- |
| DrugBank Description: | -- |
| PubChem ID: | -- |
| CasNo: | -- |
| Repositioning for NAFLD: | No |
| SMILES: | -- |
| InChiKey: | -- |
| Molecular Weight: | -- |
| DrugBank Targets: | -- |
| DrugBank MoA: | -- |
| DrugBank Pharmacology: | -- |
| DrugBank Indication: | -- |
| Targets: | FXR agonist |
| Therapeutic Category: | -- |
| Clinical Trial Progress: | Phase 2 on-going (NCT04773964) |
| Latest Progress: | Under clinical trials |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted | |
|---|---|---|---|---|---|---|---|
| L0261 | NCT04773964 | Phase 2 | Active, not recruiting | No Results Available | March 3, 2021 | September 20, 2021 | Details |
| L0437 | ACTRN12620000104954 | Phase 1 | Not Recruiting | No Results Available | 05/02/2020 | 20 September 2021 | Details |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|